Related Experiment Video

Updated: Mar 22, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K

Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases

Hiroaki Yokote1, Hidehiro Mizusawa2

  • 1Department of Neurology, Nakano General Hospital, Tokyo, Japan; Department of Neurology and Neurological Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Neural Regeneration Research
|April 30, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Experiment Videos

Last Updated: Mar 22, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.4K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K

Articles linked to this work by shared authors, journal, and citation graph.

[HIV-Associated Neurocognitive Disorders (HAND)].

Brain and nerve = Shinkei kenkyu no shinpo·2026

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

Multiple sclerosis and related disorders·2026

Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progression.

Multiple sclerosis and related disorders·2026

Wearable-based physiological monitoring and brain magnetic resonance imaging metrics in multiple sclerosis: A feasibility study.

Journal of neuroimmunology·2025

Natalizumab-Associated Progressive Multifocal Leukoencephalopathy After Natalizumab Extended Interval Dosing Therapy in Japan.

Neurology(R) neuroimmunology & neuroinflammation·2025

Slowly expanding lesions are associated with disease activity and gray matter loss in relapse-onset multiple sclerosis.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2024

Basic principles for astrocyte-to-neuron conversion.

Neural regeneration research·2026

Axonal pathology and impaired axo-glial crosstalk as early drivers of neurodegeneration.

Neural regeneration research·2026

Gut-to-brain signaling: New frontiers in treating brain disorders.

Neural regeneration research·2026

Lycium barbarum glycopeptide protects against inherited retinal degeneration in rd10 mice by regulating phototransduction and neuroinflammatory pathways.

Neural regeneration research·2026

Exosomes enriched with microRNA mimics or inhibitors: A possible treatment modality for diabetic retinopathy.

Neural regeneration research·2026

Exosome research and neuroimaging techniques: Visualization analysis of development trends and research hotspots.

Neural regeneration research·2026

Impulse Control Disorders Are Independent of Parkinson Disease Motor Subtypes.

medRxiv : the preprint server for health sciences·2026

Neuroinflammation-associated thalamocortical functional connectivity and cognition in older adults.

Journal of neuroinflammation·2026

Neuroglobin positively regulates YTHDF3 to restore mitophagy and suppress ferroptosis in sevoflurane-induced developmental neurotoxicity.

Chemico-biological interactions·2026

Repetitive nerve stimulation in juvenile myasthenia gravis: Diagnostic strategy and area decrement value.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026

Elevated primary motor cortex GABA in Parkinson's disease: 7T MR spectroscopy evidence.

Parkinsonism & related disorders·2026

Non-canonical modulation of mitochondrial ROS and dynamics by Netrin-3 drives inflammasome activation in cardiomyocytes.

International immunopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us